Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 82,791 | reported | 20 Mar 2026 | tx 42+473,228−104,222 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2,989 | 66.75 USD | |
| 18 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 3,610 | 68.71 USD | |
| 19 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,589 | 67.00 USD | |
| 17 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 3,125 | 69.42 USD | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 26,287 | — | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,020 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,148 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5,022 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5,097 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 17,161 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 27,310 | 0.00 USD | deriv |
| 04 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 8,366 | 76.67 USD | |
| 16 Dec 2025 | GIFT | Tarsus Pharmaceuticals, Inc. | 475 | 0.00 USD | |
| 16 Dec 2025 | GIFT | Tarsus Pharmaceuticals, Inc. | 950 | 0.00 USD | |
| 18 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2,605 | 46.29 USD | |
| 19 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2,543 | 47.40 USD | |
| 20 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2,435 | 50.11 USD | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 21,264 | — | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,148 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,019 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5,097 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30,628 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 20,089 | 0.00 USD | deriv |
| 15 Mar 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 13,245 | — | |
| 18 Mar 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 4,879 | 30.60 USD |